Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Solon Eiendom ASA : Key information relating to the cash dividend proposed


Posted on: 28 Feb 18

Oslo, 28 February 2018: Solon Eiendom ASA (OSE: SOLON)


Dividend amount: NOK 1.15 per share

Declared currency: NOK

Last day including right: 23 May 2018

Ex-date: 24 May 2018

Record date: 25 May 2018

Payment date: 4 June 2018

Date of approval: 23 May 2018


This information is subject to the disclosure requirements set out in section 5-12 of the Norwegian Securities Trading Act.

Further information
Andreas Martinussen
Chief Executive Officer, Solon Eiendom ASA
E-mail: am@soloneiendom.no Cell Phone: +47 400 00 405

Scott Danielsen
Chief Financial Officer, Solon Eiendom ASA
E-mail: sd@soloneiendom.no Cell Phone: +47 952 55 620

About Solon Eiendom
Solon Eiendom is a Norwegian residential real estate development company focusing on the Oslo and Akershus region.


 

Attachment:

http://www.globenewswire.com/NewsRoom/AttachmentNg/60904725-8d30-404f-8969-fac64428bed1

GlobeNewswire
globenewswire.com

Last updated on: 28/02/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.